Outcome of GATT Combined With Goniosynechiolysis in Glaucoma Patients With Secondary Synechial Angle Closure.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorKasr El Aini Hospital

About this trial

To evaluate the intraocular pressure reduction effect of combined gonioscopy-assisted transluminal trabeculotomy (GATT) with goniosynechialysis in eyes with secondary synechial angle closure glaucoma.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with secondary synechial angle closure glaucoma

Involving more than 180 degrees of the iridocorneal angle

Requiring surgery for uncontrolled IOP despite maximum tolerated therapy.

Disqualifiers

Eyes with PACG.

Eyes with neovascular glaucoma. (Some apparently stable NVG cases would have remnants of neo-vessels in the angle that are hidden behind the synechiae).

Eyes with retinal pathology.

Eyes requiring combined phacoemulsification and GATT.

Trial design

Design model

Single group

Treatments tested in this trial

  • Gonioscopy-Assisted Transluminal Trabeculotomy Combined with Goniosynechiolysis

    Other intervention

    Gonioscopy-Assisted Transluminal Trabeculotomy Combined with Goniosynechiolysis in Glaucoma Patients with Secondary Synechial Angle Closure

Treatment groups

23 Participants
are divided into 1 treatment group
Group A: Gatt combined with goinosynechiolysis in secondary synechial angle closureOther 1 intervention

Trial outcomes

Primary outcomes

1

IOP and glaucoma medications.

measurement of intra ocular pressure and documentation of number of anti glaucoma medications post operative

Time frame
1day,1 week,1 months, 3 months, 6 months and 1 year
2

Surgical success.

Surgical success will be defined as: complete if IOP is less than or equal to 21mmHg without medications and qualified success if IOP is less than or equal to 21mmHg with medications. Failure will be the inability to achieve such a pressure, the need for another glaucoma operation or the development of a sight-threatening complication (e.g., retinal detachment, endophthalmitis)

Time frame
1day,1 week,1 months, 3 months, 6 months and 1 year

Secondary outcomes

1

Complications.

rate of complications will be recorded

Time frame
1day,1 week,1 months, 3 months, 6 months and 1 year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.